Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Hong Kong court finds tycoon Jimmy Lai guilty in landmark security trial
School bus accident in Colombia kills 17, injures 20
Australia plans tougher gun laws after father and son kill 15 at Bondi Beach
Police to release man detained over Brown University mass shooting
Shooting at Australia's Bondi Beach kills 12
